Healthcare Merger and Acquisition: Transcarent Acquires Seattle-based Health Benefits Firm Accolade for $621M

Healthcare M&A News: Transcarent to Acquire Accolade for $621M

Recently, Seattle-based Accolade announced that it will be acquired by Transcarent, a move that brings together two leading health benefits companies. The acquisition will see Transcarent purchasing Accolade for $7.03 per share in cash, totaling $621 million. This deal represents a significant premium of approximately 110% over Accolade’s closing stock price from the previous day.

Both companies have a shared goal of assisting self-insured companies and their employees in navigating healthcare options effectively. Transcarent’s acquisition of Accolade is backed by equity financing from General Catalyst and 62 Ventures, providing the resources necessary to support their mission.

Accolade, founded in 2007, offers healthcare delivery, navigation, and advocacy services through employers. Under the leadership of Raj Singh, a seasoned tech executive, Accolade went public in 2020 before the recent acquisition. Singh highlighted the joint commitment of both companies to utilize AI and advanced technology to revolutionize the consumer healthcare experience.

Transcarent, established in 2020, secured $126 million in a Series D funding round in May, reaching a valuation of $2.2 billion. The company had previously acquired a portion of Seattle-based healthcare tech firm 98point6 in 2023, further expanding its reach in the healthcare sector.

Accolade reported $106.4 million in revenue for its fiscal quarter ending Aug. 31, showing a 10% year-over-year growth. Despite experiencing a net loss, the company remains focused on innovation and growth in the healthcare industry.

With additional offices across various locations, including San Francisco, El Paso, and Prague, Accolade is positioned for continued expansion and success under the leadership of Raj Singh. Singh, who previously led Concur before the company’s acquisition by SAP in 2014, brings a wealth of experience to his role at Accolade.

The future looks promising for Accolade and Transcarent as they join forces to enhance healthcare delivery, personalize the consumer experience, drive better outcomes, and reduce costs in the healthcare sector.